Photodynamic Therapy in Treating Patients With Skin Cancer
Completed · Phase 2
Conditions studied: Non-melanomatous Skin Cancer
In brief
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy works in treating patients with skin cancer.
Key facts
- Study ID
- NCT00002963
- Run by
- Roswell Park Cancer Institute
- Starts
- 1993-11-01
- Expected to finish
- 2007-06-01
- Last updated by the study team
- 2013-01-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.